Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis J Picker

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Nature Medicine|September 11, 2012
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccinesYoshinori Fukazawa, Haesun Park, Mark J Cameron, et al.
Science (New York, N.Y.)|May 25, 2013
Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigmsScott G Hansen, Jonah B Sacha, Colette M Hughes, et al.
Nature|June 22, 2017
Addendum: Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Cell Host & Microbe|July 12, 2019
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 InfectionsAlexandra M Bender, Francesco R Simonetti, Mithra R Kumar, et al.
Journal of Virology|May 29, 2015
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman PrimatesXiaoying Shen, Ryan Duffy, Robert Howington, et al.
Plos Pathogens|August 22, 2024
Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistenceBenjamin Varco-Merth, Morgan Chaunzwa, Derick M Duell, et al.
Science Immunology|March 26, 2021
Cytomegaloviral determinants of CD8<sup>+</sup> T cell programming and RhCMV/SIV vaccine efficacyDaniel Malouli, Scott G Hansen, Meaghan H Hancock, et al.
The Journal of Clinical Investigation|January 29, 2026
Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 reboundWere R Omange, Benjamin D Varco-Merth, Omo Fadeyi, et al.
Science Immunology|June 17, 2022
Myeloid cell tropism enables MHC-E-restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccineScott G Hansen, Meaghan H Hancock, Daniel Malouli, et al.
Nature Microbiology|January 30, 2026
Initial sites of SIV rebound after antiretroviral treatment cessation in rhesus macaquesBrandon F Keele, Afam A Okoye, Taina T Immonen, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Nature Medicine|September 11, 2012
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccinesYoshinori Fukazawa, Haesun Park, Mark J Cameron, et al.
Science (New York, N.Y.)|May 25, 2013
Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigmsScott G Hansen, Jonah B Sacha, Colette M Hughes, et al.
Nature|June 22, 2017
Addendum: Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Cell Host & Microbe|July 12, 2019
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 InfectionsAlexandra M Bender, Francesco R Simonetti, Mithra R Kumar, et al.
Journal of Virology|May 29, 2015
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman PrimatesXiaoying Shen, Ryan Duffy, Robert Howington, et al.
Plos Pathogens|August 22, 2024
Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistenceBenjamin Varco-Merth, Morgan Chaunzwa, Derick M Duell, et al.
Science Immunology|March 26, 2021
Cytomegaloviral determinants of CD8<sup>+</sup> T cell programming and RhCMV/SIV vaccine efficacyDaniel Malouli, Scott G Hansen, Meaghan H Hancock, et al.
The Journal of Clinical Investigation|January 29, 2026
Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 reboundWere R Omange, Benjamin D Varco-Merth, Omo Fadeyi, et al.
Science Immunology|June 17, 2022
Myeloid cell tropism enables MHC-E-restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccineScott G Hansen, Meaghan H Hancock, Daniel Malouli, et al.
Nature Microbiology|January 30, 2026
Initial sites of SIV rebound after antiretroviral treatment cessation in rhesus macaquesBrandon F Keele, Afam A Okoye, Taina T Immonen, et al.
Pageof 15